Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
G-Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption. These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them, offering personalised treatment to the 'smoker' which significantly increases their chances of quitting.
Incorporated in June 2004
Origin: Oxford University, Sir William Dunn School of Pharmacology
Improving the lives of people living with Parkinson’s.
Incorporated in March 2020
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.
Incorporated in March 2014
Origin: Oxford University, Wellcome Trust Centre for Human Genetics
Global Campus supports sustainable, integrated and interuniversity learning opportunities, reinvesting profits in scholarships for students and/or building capacity in local heritage structures.
Incorporated in October 2020
Origin: Oxford University, International Development
Aim is to accelerate and streamline research through an innovative digital platform for knowledge sharing.
Incorporated in July 2020
Origin: Oxford University, Tropical Medicine
Malaria vaccine development.
Incorporated in September 2019
Origin: Oxford University, Jenner Institute
GPAS is now part of EIT Pathogena, a cutting-edge genomic analysis platform for academics and public health professionals around the world to help fight infectious diseases.
Incorporated in December 2021
Origin: Oxford University, Nuffield Department of Medicine
The company is focused on the use of bacteriocins and anti-microbial therapies.
Incorporated in April 2023
Origin: Oxford University, Biochemistry
Glycosolation technology.
Incorporated in August 2002
Origin: Oxford University, Organic Chemistry
A new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.
Incorporated in July 2024
Origin: Oxford University, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS)
Personalised cash grants to help people out of homelessness for good. £1,319 spent by Greater Change unlocks £35,177 in cost savings to the government. A return of over 20x.
Incorporated in March 2019
Origin: Oxford University, Department of Economica
Mining large digital pathology datasets through a web platform that can manage a crowd sourced approach to annotation.
Incorporated in December 2019
Origin: Oxford University, IBME and NDM
Developing international trade and transport simulators, using mathematical models and machine learning.
Incorporated in November 2020
Origin: Oxford University, Department of Computer Science
Contact: Adrian Coles
GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.
Incorporated in July 2019
Origin: Oxford University
Behaviour-based analytics.
Incorporated in February 2021
Origin: Oxford University, Department of Computer Science
LED spin-out using Perovskite technology.
Incorporated in September 2018
Origin: Oxford University, Department of Physics
Custom made helmet using 3D printing.
Incorporated in June 2018
Origin: Oxford University, Department of Engineering Science
To discover significantly de-risked novel drug targets for licensing and in-house development.
Incorporated in December 2021
Origin: Oxford University, Nuffield Department of Clinical Medicine
Cleaner, safer, faster chemical production.
Incorporated in February 2021
Origin: Oxford University, Department of Chemistry
Inkpath is a skills tracking app which helps it's users plan and track their career development in a smart format.
Incorporated in July 2017
Origin: Oxford University
